Data Integrity & Digital Pharma Operations – Page 16

Manual result override risks in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Data integrity issues in LIMS can often manifest through various symptoms that signal potential problems in the system. Common indicators include:Click to read the full article.

How to Prevent Sequence Deletion and Sample Omission in CDS (Chromatography Data System) Risks

Identifying early symptoms of CDS data integrity risks is crucial for timely intervention. Observations that may indicate potential problems include:Click to read the full article.

How to Respond When Inspectors Question Missing Raw Data

Data integrity issues often manifest as a series of flags during manufacturing processes, laboratory work, or in documentation. The key symptoms to watch for include:Click to read the full article.

Unapproved retest workflows in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Identifying symptoms of LIMS data integrity issues is essential to prevent regulatory non-compliance and quality failures. Common signs include:Click to read the full article.

Uncontrolled Processing Methods: Root Causes, GMP Risks, and CAPA Controls

Identifying symptoms of uncontrolled processing is critical. These may manifest as irregularities in data, unexpected results, or failures during routine checks. Common signals on the floor or in the lab…

Data Integrity During Inspections: Checklist for Electronic and Hybrid Records

Ensuring Data Integrity During Regulatory Inspections: A Comprehensive Checklist In the pharmaceutical manufacturing and quality sectors, maintaining data integrity is critical, especially during regulatory inspections. Inadequate management of electronic and…

Unapproved retest workflows in LIMS test assignment workflows: Data Integrity Risks and Corrective Controls

Identifying data integrity issues early can significantly reduce risks in the laboratory environment. Symptoms signaling LIMS data integrity issues may include:Click to read the full article.

Inspection-Ready Approach to Peak Integration Changes in Pharmaceutical Operations

The first step in addressing peak integration changes is to recognize the symptoms that signify potential data integrity issues. Symptoms may appear during routine audits, sample analyses, or even within…

How to Demonstrate ALCOA+ Compliance During Regulatory Inspections

Before addressing compliance with ALCOA+, it is crucial to recognize the warning signs indicating potential data integrity issues. Common symptoms may include:Click to read the full article.

Unapproved retest workflows in LIMS result entry and review: Data Integrity Risks and Corrective Controls

Identifying symptoms of LIMS data integrity issues early is crucial for maintaining compliance. Some prevalent signs include:Click to read the full article.

Why Blank and System Suitability Manipulation Happens and How QA Teams Should Control It

Identifying symptoms of blank and system suitability manipulation within a chromatography data system (CDS) is essential. These symptoms can manifest in various forms:Click to read the full article.

Inspection Room Strategy for Data Integrity Questions in Pharma Sites

Every pharmaceutical facility should maintain an acute awareness of potential indicators of data integrity issues. In our case study, the first signal arose when a quality control analyst noted discrepancies…